Sign inJoin waitlistJoin the waitlist

Daniel Shu

Assistant Professor · Univ of Maryland Sch of Med

Credentials: · · · ·

History

Univ of Maryland Sch of Med · University of Maryland School of Medicine · University of Maryland Capital Region Health
Present

Johns Hopkins Hospital
2022–2024
Internal Medicine
Johns Hopkins University School of Medicine
2017–2020
Temple University School of Medicine
2013–2017

Research

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Nature Medicine · 2024 · 214 citations
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
Nature Immunology · 2024 · First of 39 authors · 97 citations
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis
The Lancet Oncology · 2024 · 72 citations

Mark Yarchoan
13 papers
Elizabeth Jaffee
10 papers
WH
Won Jin Ho
10 papers
Robert Anders
8 papers
MB
Marina Baretti
7 papers · 6 as a fellow
DZ
Daniel Zabransky
5 papers · 2 as a fellow
Daniel Laheru
4 papers
Jae Lee
3 papers · 3 as a fellow
NZ
Neeha Zaidi
3 papers
Nilofer Azad
3 papers
CK
Chester Kao
2 papers
EH
Elsa Hallab
2 papers · 2 as a resident

Clinical trials

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2026–2027